Biological Sample Collection Kits Market by Product Type (Blood Collection Kits, Swabs, Viral Transport Media), Sample Type (Blood, Saliva, Stool), Application, End-User - Global Forecast 2024-2030

Biological Sample Collection Kits Market by Product Type (Blood Collection Kits, Swabs, Viral Transport Media), Sample Type (Blood, Saliva, Stool), Application, End-User - Global Forecast 2024-2030

The Biological Sample Collection Kits Market size was estimated at USD 8.60 billion in 2023 and expected to reach USD 9.31 billion in 2024, at a CAGR 8.57% to reach USD 15.29 billion by 2030.

Biological sample collection kits are specialized packages designed to facilitate the collection, storage, and transportation of various biological samples for research, diagnostic, and therapeutic purposes. These kits contain all necessary components, such as swabs, vials, tubes, and preservative fluids, ensuring the integrity and viability of the samples from the point of collection to analysis. The emergence of infectious diseases and the ongoing need for medical research amplify the requirement for efficient biological sample collection methods. Growing innovations in genomics, proteomics, and metabolomics necessitate robust sample collection solutions to support complex analyses. The availability of stringent regulations regarding sample collection, storage, and transportation encourages the adoption of standardized collection kits that comply with international standards. The emerging trend toward point-of-care and at-home testing solutions has increased the need for user-friendly and reliable sample collection kits. High development and maintenance of high-quality collection kits are impacting their adoption, especially in resource-limited settings, hampering the growth of the market. Ongoing improvements in sample preservation techniques and materials that enhance the performance and utility of collection kits are expected to create opportunities for market growth.

Regional Insights

The Americas represents a significant market for biological sample collection kits due to the robust healthcare infrastructure, high healthcare spending, and the presence of a large number of key players in the region. North America is the significant contributor, driven by advanced research facilities, rising investments in diagnostics and personalized medicine, and growing awareness regarding disease diagnosis. Additionally, the increasing prevalence of chronic diseases and the strong focus on healthcare innovation in countries including Canada and Brazil further augment the demand for these kits. Regulatory support for quality healthcare services and an established network for early disease detection and monitoring also play a crucial role in market growth. The Asia-Pacific region is witnessing rapid growth in the biological sample collection kits market, attributed to its expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness regarding the importance of early diagnosis. Countries including China and India, with their large population bases and increasing prevalence of infectious and non-infectious diseases, present significant opportunities for market expansion. The area is also seeing a rise in governmental and private investment in healthcare research and development, adding to the demand for collection kits. The EMEA region's market for biological sample collection kits is diverse due to the high demand for advanced healthcare facilities, a well-established pharmaceutical and biotechnology research sector, and supportive governmental healthcare policies across countries such as Germany, the UK, and France. The Middle East and Africa are expected to grow, driven by the gradual improvement in healthcare infrastructure, increasing awareness about health among the population, and rising investments in healthcare by governments, especially in the Gulf Cooperation Council (GCC) countries.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biological Sample Collection Kits Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Rising emergence of infectious diseases and the ongoing need for medical research
• Availability of stringent regulations regarding sample collection, storage, and transportation
• Increasing development of diagnostic centers worldwide

Market Restraints

• Complexity in the maintenance of high-quality collection kits

Market Opportunities

• Ongoing technological improvements in biological sample collection kits
• Emerging trend towards point-of-care and at-home testing solutions

Market Challenges

• Improper design of kits and inaccuracy of results

Market Segmentation Analysis

• Product Type: Growing usage of blood collection kits for the efficient and safe collection of blood samples
• End-User: High potential of blood collection kits across diagnostic centers for collecting various types of biological samples

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biological Sample Collection Kits Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biological Sample Collection Kits Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Takara Bio’s First-to-market Large-Scale Single-cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery

Takara Bio USA, Inc. announced the imminent release of revolutionary automated library preparation kits for oncology research, namely the Shasta™ Total RNA-Seq Kit and the Shasta Whole-Genome Amplification Kit. These pioneering solutions are set to redefine the landscape of single-cell analysis by offering unparalleled capacity, efficiency, and depth of genetic information. The Shasta Total RNA-Seq Kit will empower researchers to conduct comprehensive transcriptome profiling of up to 100,000 single cells in a single run, enabling the detection of splicing isoforms, gene fusions, and non-polyadenylated RNAs.

BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Becton, Dickinson, and Company (BD), a global medical technology, has recently achieved 510(k) clearance from the FDA for its innovative BD MiniDraw Capillary Blood Collection System. This advanced system introduces a less invasive method for blood sample collection directly from a fingerstick, promising laboratory-quality outcomes for a range of commonly performed blood tests. Specifically designed for operation by skilled healthcare professionals, its deployment in inaccessible locations such as retail pharmacies represents an important step forward in making essential blood testing more available to patients who might otherwise find it challenging to access traditional commercial laboratory services.

Cue Health's New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health

Cue Health has announced the nationwide availability of its new line of user-friendly, at-home diagnostic test kits, revolutionizing access to health testing. Designed for utmost convenience and accuracy, these kits seamlessly integrate with Cue Care, the company's advanced test-to-treatment platform, offering a comprehensive healthcare solution from home. With each kit providing the necessary components for discreet and simple sample collection, users can expect quick, understandable results via the Cue Health App, accompanied by actionable insights.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biological Sample Collection Kits Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Collection Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Eurofins Scientific SE, Exelint International, Co., F. Hoffmann-La Roche Ltd., F.L. Medical S.r.l., Globe Scientific Inc., Greiner AG, Haemonetics Corporation, ICU Medical, Inc., Medtronic PLC, Merck KGaA, Nipro Medical Corporation, Qiagen N.V., Retractable Technologies, Inc., Siemens Healthineers AG, Terumo Corporation, Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biological Sample Collection Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
• Blood Collection Kits
• Swabs
• Viral Transport Media
• Sample Type
• Blood
• Saliva
• Stool
• Tissue
• Urine
• Application
• Diagnostics
• Treatment
• End-User
• Blood Banks
• Diagnostic Centers
• Hospitals

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year